Nifty
Sensex
:
:
17094.35
57426.92
276.25 (1.64%)
1016.96 (1.80%)

Pharmaceuticals & Drugs - API

Rating :
56/99

BSE: 532482 | NSE: GRANULES

345.35
30-Sep-2022
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 331.95
  • 347.00
  • 325.05
  • 324.30
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  9384379
  •  31785.27
  •  362.40
  •  226.95

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 8,572.31
  • 20.40
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 9,255.61
  • 0.43%
  • 3.18

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 41.98%
  • 4.09%
  • 25.25%
  • FII
  • DII
  • Others
  • 23.13%
  • 3.03%
  • 2.52%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.29
  • 17.45
  • 13.15

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 23.85
  • 20.98
  • 6.56

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 28.91
  • 28.77
  • 10.02

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.70
  • 15.94
  • 16.11

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.34
  • 2.79
  • 3.32

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.73
  • 10.55
  • 10.75

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Net Sales
1,019.56
849.85
19.97%
1,029.97
799.31
28.86%
996.77
844.51
18.03%
888.33
858.12
3.52%
Expenses
808.05
648.42
24.62%
837.27
597.31
40.17%
823.04
632.95
30.03%
737.15
601.71
22.51%
EBITDA
211.50
201.43
5.00%
192.70
202.01
-4.61%
173.73
211.56
-17.88%
151.18
256.41
-41.04%
EBIDTM
20.74%
23.70%
18.71%
25.27%
17.43%
25.05%
17.02%
29.88%
Other Income
4.67
7.62
-38.71%
3.96
3.28
20.73%
4.87
16.41
-70.32%
4.35
3.22
35.09%
Interest
6.94
6.79
2.21%
6.36
6.82
-6.74%
4.59
7.24
-36.60%
5.46
6.27
-12.92%
Depreciation
43.36
39.38
10.11%
40.18
44.48
-9.67%
39.23
36.85
6.46%
39.84
36.06
10.48%
PBT
165.87
162.87
1.84%
150.12
153.99
-2.51%
134.78
183.88
-26.70%
110.23
217.30
-49.27%
Tax
38.30
42.67
-10.24%
39.12
26.42
48.07%
33.90
37.08
-8.58%
29.55
53.67
-44.94%
PAT
127.57
120.20
6.13%
111.00
127.57
-12.99%
100.88
146.81
-31.29%
80.68
163.63
-50.69%
PATM
12.51%
14.14%
10.78%
15.96%
10.12%
17.38%
9.08%
19.07%
EPS
5.14
4.85
5.98%
4.48
5.15
-13.01%
4.07
5.93
-31.37%
3.26
6.61
-50.68%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
3,934.63
3,764.92
3,237.54
2,598.65
2,279.20
1,684.62
1,410.57
1,357.18
1,292.92
1,095.86
764.37
Net Sales Growth
17.39%
16.29%
24.59%
14.02%
35.29%
19.43%
3.93%
4.97%
17.98%
43.37%
 
Cost Of Goods Sold
2,008.11
1,883.64
1,391.28
1,280.93
1,255.56
896.32
679.63
725.03
746.95
645.25
466.92
Gross Profit
1,926.52
1,881.28
1,846.27
1,317.72
1,023.64
788.30
730.93
632.15
545.97
450.61
297.45
GP Margin
48.96%
49.97%
57.03%
50.71%
44.91%
46.79%
51.82%
46.58%
42.23%
41.12%
38.91%
Total Expenditure
3,205.51
3,043.30
2,382.31
2,073.33
1,895.16
1,406.20
1,111.73
1,081.29
1,084.31
937.57
679.35
Power & Fuel Cost
-
74.66
68.85
59.74
57.67
48.22
38.67
34.97
45.73
36.70
37.71
% Of Sales
-
1.98%
2.13%
2.30%
2.53%
2.86%
2.74%
2.58%
3.54%
3.35%
4.93%
Employee Cost
-
366.44
324.29
259.04
209.82
165.21
140.19
117.57
106.96
85.84
59.71
% Of Sales
-
9.73%
10.02%
9.97%
9.21%
9.81%
9.94%
8.66%
8.27%
7.83%
7.81%
Manufacturing Exp.
-
298.74
228.39
177.94
157.62
120.84
88.60
66.97
50.89
38.68
24.34
% Of Sales
-
7.93%
7.05%
6.85%
6.92%
7.17%
6.28%
4.93%
3.94%
3.53%
3.18%
General & Admin Exp.
-
134.41
172.28
125.63
99.96
83.05
67.65
60.38
59.84
44.42
26.96
% Of Sales
-
3.57%
5.32%
4.83%
4.39%
4.93%
4.80%
4.45%
4.63%
4.05%
3.53%
Selling & Distn. Exp.
-
247.45
159.80
112.17
91.84
83.08
81.37
67.75
71.70
85.04
61.70
% Of Sales
-
6.57%
4.94%
4.32%
4.03%
4.93%
5.77%
4.99%
5.55%
7.76%
8.07%
Miscellaneous Exp.
-
37.96
37.42
57.88
22.69
9.49
15.61
8.62
2.24
1.64
61.70
% Of Sales
-
1.01%
1.16%
2.23%
1.00%
0.56%
1.11%
0.64%
0.17%
0.15%
0.26%
EBITDA
729.11
721.62
855.23
525.32
384.04
278.42
298.84
275.89
208.61
158.29
85.02
EBITDA Margin
18.53%
19.17%
26.42%
20.22%
16.85%
16.53%
21.19%
20.33%
16.13%
14.44%
11.12%
Other Income
17.85
18.22
26.88
36.56
26.68
10.84
9.93
5.62
4.34
4.31
2.06
Interest
23.35
23.21
26.28
27.02
28.46
33.06
32.26
37.07
32.35
20.43
17.67
Depreciation
162.61
158.63
151.46
136.95
105.48
76.20
71.51
58.40
52.65
29.81
23.08
PBT
561.00
558.00
704.36
397.90
276.78
180.00
204.99
186.03
127.96
112.36
46.32
Tax
140.87
145.24
154.91
115.73
89.11
63.40
65.20
61.15
37.05
37.13
13.76
Tax Rate
25.11%
26.03%
21.99%
27.19%
32.20%
35.22%
31.81%
32.87%
28.95%
33.05%
29.71%
PAT
420.13
412.76
549.46
309.91
187.67
116.60
139.79
124.89
90.91
75.23
32.57
PAT before Minority Interest
420.13
412.76
549.46
309.91
187.67
116.60
139.79
124.89
90.91
75.23
32.57
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
10.68%
10.96%
16.97%
11.93%
8.23%
6.92%
9.91%
9.20%
7.03%
6.86%
4.26%
PAT Growth
-24.74%
-24.88%
77.30%
65.14%
60.95%
-16.59%
11.93%
37.38%
20.84%
130.98%
 
EPS
16.94
16.64
22.16
12.50
7.57
4.70
5.64
5.04
3.67
3.03
1.31

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
2,586.53
2,173.27
1,843.72
1,529.47
1,304.18
903.60
661.60
431.16
355.96
274.85
Share Capital
24.80
24.77
25.42
25.42
25.38
22.87
21.67
20.43
20.28
20.13
Total Reserves
2,545.01
2,126.23
1,800.02
1,493.09
1,273.38
878.28
611.13
410.74
335.43
254.41
Non-Current Liabilities
282.83
366.30
485.98
552.63
488.19
187.99
246.62
356.52
343.51
202.00
Secured Loans
233.70
333.81
414.83
478.78
433.13
123.90
183.66
302.59
295.86
174.85
Unsecured Loans
0.00
0.00
6.69
0.00
0.00
0.34
0.55
0.62
13.38
0.65
Long Term Provisions
28.31
24.84
21.50
12.58
7.70
7.25
5.58
4.03
3.97
2.04
Current Liabilities
1,641.60
1,173.10
893.40
896.48
877.91
787.13
654.75
415.03
292.54
205.78
Trade Payables
638.61
541.05
356.88
323.48
274.35
215.98
181.10
187.63
135.54
91.84
Other Current Liabilities
200.85
194.25
153.16
113.60
69.84
93.43
79.21
88.98
47.78
23.77
Short Term Borrowings
765.58
409.27
371.69
454.21
525.10
473.83
392.85
124.97
100.91
85.46
Short Term Provisions
36.56
28.53
11.66
5.20
8.62
3.90
1.58
13.45
8.30
4.71
Total Liabilities
4,511.52
3,712.67
3,223.10
2,978.58
2,670.28
1,878.72
1,562.97
1,202.71
992.01
682.63
Net Block
1,541.17
1,332.00
1,203.97
944.25
776.73
644.34
559.94
616.55
482.47
263.46
Gross Block
2,461.76
2,145.15
1,875.23
1,472.94
1,199.63
983.66
822.98
843.76
653.90
387.41
Accumulated Depreciation
920.59
813.15
671.26
528.69
422.90
339.32
263.05
227.21
171.43
123.95
Non Current Assets
2,006.54
1,715.68
1,594.41
1,696.34
1,483.71
1,050.55
744.97
699.69
611.55
388.87
Capital Work in Progress
356.23
239.08
294.20
495.95
514.52
267.43
76.56
62.03
124.56
108.80
Non Current Investment
19.67
18.99
19.34
210.42
156.56
108.23
70.11
0.19
0.19
0.19
Long Term Loans & Adv.
89.47
125.61
76.89
45.72
35.91
30.56
38.37
20.76
4.33
16.42
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.15
0.00
0.00
Current Assets
2,504.98
1,997.00
1,628.70
1,282.24
1,186.57
828.16
818.00
500.36
376.92
288.88
Current Investments
0.00
0.00
109.85
0.00
0.00
0.00
0.00
0.00
0.00
9.46
Inventories
978.55
782.18
438.43
384.21
279.95
269.18
253.72
224.52
174.16
136.48
Sundry Debtors
924.95
765.42
662.04
673.54
628.25
417.70
375.35
136.91
110.91
71.02
Cash & Bank
409.46
271.04
283.94
89.04
115.64
49.80
130.29
65.31
41.75
41.71
Other Current Assets
192.02
50.74
42.60
36.99
162.73
91.49
58.65
73.63
50.10
30.21
Short Term Loans & Adv.
130.35
127.61
91.83
98.46
114.09
51.66
48.68
2.05
28.76
16.93
Net Current Assets
863.38
823.90
735.30
385.76
308.65
41.03
163.25
85.33
84.38
83.09
Total Assets
4,511.52
3,712.68
3,223.11
2,978.58
2,670.28
1,878.71
1,562.97
1,202.72
992.01
682.64

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
332.05
432.48
476.19
262.24
-0.65
188.24
151.43
150.28
107.95
91.18
PBT
558.00
704.36
425.64
276.78
180.00
204.99
186.03
127.96
112.36
46.32
Adjustment
176.29
194.43
156.88
149.85
107.45
95.14
92.63
85.37
50.39
41.46
Changes in Working Capital
-257.19
-274.95
12.75
-75.94
-230.03
-52.37
-79.70
-31.34
-31.03
14.60
Cash after chg. in Working capital
477.10
623.84
595.27
350.69
57.42
247.77
198.97
182.00
131.73
102.39
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-145.05
-191.37
-119.08
-88.45
-58.07
-59.53
-47.54
-31.72
-23.78
-11.20
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-380.11
-277.13
-160.63
-269.82
-462.31
-326.09
-161.65
-145.55
-254.63
-127.79
Net Fixed Assets
-302.61
-204.42
-124.57
-176.36
-282.01
-249.86
-75.62
-231.53
-64.60
-89.18
Net Investments
-5.00
-36.29
-48.78
-431.34
-0.01
13.84
-16.48
72.98
-94.69
-17.96
Others
-72.50
-36.42
12.72
337.88
-180.29
-90.07
-69.55
13.00
-95.34
-20.65
Cash from Financing Activity
190.00
-299.31
-212.85
-17.43
528.62
55.87
85.67
18.83
146.72
46.33
Net Cash Inflow / Outflow
141.94
-143.97
102.70
-25.01
65.66
-81.98
75.44
23.56
0.04
9.72
Opening Cash & Equivalents
41.84
185.93
83.02
108.03
42.37
124.35
54.85
41.75
41.71
31.98
Closing Cash & Equivalent
184.71
41.84
185.93
83.02
108.03
42.37
130.29
65.31
41.75
41.71

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
103.62
86.85
71.80
59.73
51.17
39.40
29.20
20.98
17.36
13.40
ROA
10.04%
15.84%
9.99%
6.64%
5.13%
8.12%
9.03%
8.31%
8.98%
5.19%
ROE
17.49%
27.64%
18.54%
13.32%
10.60%
18.23%
23.53%
23.29%
24.20%
12.67%
ROCE
17.37%
25.42%
17.22%
12.71%
11.09%
16.57%
20.16%
18.75%
19.90%
12.95%
Fixed Asset Turnover
2.26
1.97
1.75
1.78
1.55
1.59
1.66
1.77
2.14
2.11
Receivable days
59.15
65.94
83.34
100.03
112.83
100.84
67.60
33.47
29.73
38.66
Inventory Days
61.61
56.39
51.34
51.03
59.23
66.49
63.11
54.79
50.77
57.37
Payable days
114.29
117.79
58.20
54.96
62.37
64.87
59.99
53.57
43.67
44.19
Cash Conversion Cycle
6.46
4.54
76.48
96.10
109.70
102.46
70.72
34.69
36.83
51.84
Total Debt/Equity
0.43
0.39
0.49
0.65
0.75
0.73
1.01
1.14
1.25
1.00
Interest Cover
25.04
27.80
16.75
10.72
6.44
7.36
6.02
4.96
6.50
3.62

News Update:


  • Granules India gets ANDA approval for Loperamide Hydrochloride and Simethicone Tablets
    30th Aug 2022, 11:23 AM

    Granules now have a total of 52 ANDA approvals from US FDA

    Read More
  • Granules India gets USFDA’s nod for Guaifenesin and Pseudoephedrine Hydrochloride ER Tablets
    26th Aug 2022, 11:59 AM

    The company now have a total of 51 ANDA approvals from US FDA

    Read More
  • Granules India - Quarterly Results
    9th Aug 2022, 17:17 PM

    Read More
  • USFDA completes inspection at facility of Granules India’s arm
    23rd Jul 2022, 12:50 PM

    Granules Pharmaceuticals, Inc. will respond to these observations within the stipulated time period

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.